RACHEL NOTTE

Allopathic & Osteopathic Physicians|Family Medicine WARMINSTER, PA NPI 1720149503

General Payments — all program years on this page

$3,099.26

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 185
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $839.53 across 41 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $839.5341

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,022.8168
2019 $689.2549
2020 $234.019
2021 $42.532
2023 $271.1316
2024 $839.5341

Records — PY2024 (41)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086127602 Bayer Healthcare Pharmaceuticals Inc. $21.87 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086244616 Bayer Healthcare Pharmaceuticals Inc. $20.47 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096776421 Novo Nordisk Inc $24.60 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096920536 Novo Nordisk Inc $16.27 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096921738 Novo Nordisk Inc $15.95 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097062972 Novo Nordisk Inc $19.47 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097136518 Novo Nordisk Inc $18.68 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097155383 Novo Nordisk Inc $23.47 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097307413 Novo Nordisk Inc $19.63 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097595231 Novo Nordisk Inc $16.41 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104261777 AstraZeneca Pharmaceuticals LP $18.21 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104282915 AstraZeneca Pharmaceuticals LP $15.97 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104513882 AstraZeneca Pharmaceuticals LP $18.99 01/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104550932 AstraZeneca Pharmaceuticals LP $14.88 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105310134 AstraZeneca Pharmaceuticals LP $25.89 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105670591 AstraZeneca Pharmaceuticals LP $16.31 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105829847 AstraZeneca Pharmaceuticals LP $16.40 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105850888 AstraZeneca Pharmaceuticals LP $18.57 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114812045 Exact Sciences Corporation $23.33 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116530480 GlaxoSmithKline, LLC. $17.81 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116725324 GlaxoSmithKline, LLC. $18.65 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117643117 Amgen Inc. $13.32 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125217222 Abbott Laboratories $20.29 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135200047 Lilly USA, LLC $17.57 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135300583 Lilly USA, LLC $21.17 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135300587 Lilly USA, LLC $22.17 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135305232 Lilly USA, LLC $16.09 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135305236 Lilly USA, LLC $23.36 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135307390 Lilly USA, LLC $29.32 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135307394 Lilly USA, LLC $19.20 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135307398 Lilly USA, LLC $21.91 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135323706 Lilly USA, LLC $19.67 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135324296 Lilly USA, LLC $22.52 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135329467 Lilly USA, LLC $23.89 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135329471 Lilly USA, LLC $25.15 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139316476 Astellas Pharma US Inc $30.03 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139331584 Astellas Pharma US Inc $30.03 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141644321 Merck Sharp & Dohme LLC $18.86 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141644323 Merck Sharp & Dohme LLC $13.28 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150826796 Neurocrine Biosciences, Inc. $29.54 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151103117 Phathom Pharmaceuticals, Inc. $20.33 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.